Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 27 June 2003:
Vol. 300. no. 5628, pp. 2015 - 2016
DOI: 10.1126/science.300.5628.2015a
Prev | Table of Contents | Next

News of the Week

BIOTECHNOLOGY:
Sheep Fail to Produce Golden Fleece

Gretchen Vogel

The company that helped to clone Dolly the sheep is fighting for survival now that a key project has been put on ice. PPL Therapeutics announced on 19 June that a partner, the German drug giant Bayer, has suspended development of a treatment for lung ailments, one of PPL's two main potential products. In response, PPL says it will lay off up to 140 of its 165 employees and will scrap plans for a $70 million manufacturing plant.

Read the Full Text

ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)